Fundraising Fox

Crinetics Pharmaceuticals, Inc.

NASDAQ: CRNX

San Diego, US · Delaware corporation · 2 known investors

Biotech

Founders & leadership

RS
Richard Scott StruthersCo-founder
SF
Stephen F. BetzCo-founder
YZ
YunFei ZhuNamed on SEC filing

Board

MS
Mahendra ShahBoard directorSenior Fellow at Vivo Capital
SK
Steve KaldorBoard director
MF
Mason FreemanBoard director
WW
Wendell WierengaBoard director

Investors · 2

Foresite CapitalWest Hollywood
Vivo CapitalreportedPalo Alto · $10M – $50Mvia Jack Nielsen · board

Reported raises · per SEC filings

Form D private placements

$428M disclosed across 3 rounds · 2015–2024

▶$350MraisedMar 2024 · 36 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES HASSARDExecutive Officer
  • STEPHEN BETZExecutive Officer
  • ROGERIO VIVALDI COELHO, M.D.Director
  • WESTON NICHOLS, PhDDirector
  • MARC WILSONExecutive Officer
  • CAMILLE BEDROSIAN, M.D.Director
  • MATTHEW FUSTDirector
  • RICHARD SCOTT STRUTHERS, PhDExecutive Officer, Director
  • JEFF KNIGHTExecutive Officer
  • WENDELL WIERENGA, PhDDirector
  • DANA PIZZUTIExecutive Officer
  • CAREN DEARDORFDirector
  • STEPHANIE OKEYDirector
Offering amount
$350M
Amount sold
$350M
Sales commissions
$14M
Placement agents
LIFESCI CAPITAL, LLC, H.C. WAINWRIGHT & CO., LLC, ROBERT W. BAIRD & CO. INCORPORATED, PIPER SANDLER & CO., LEERINK PARTNERS LLC, CITIZENS JMP SECURITIES, LLC
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MraisedFeb 2018 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mason Freeman, M.D.Director
  • Matthew K. FustDirector
  • Wendell Wierenga, Ph.DDirector
  • Richard Scott Struthers, Ph.DExecutive Officer, Director
  • Steve Kaldor, Ph.DDirector
  • Marc WilsonExecutive Officer
  • Weston Nichols, Ph.DDirector
  • Jack B. NielsenDirector
Offering amount
$65M
Amount sold
$60M
First sale
Feb 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18MraisedNov 2015 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • YunFei ZhuExecutive Officer
  • Steve KaldorDirector
  • Mason FreemanDirector
  • Wendell WierengaDirector
  • Richard Scott StruthersExecutive Officer, Director
  • Mahendra ShahDirector
  • Stephen F. BetzExecutive Officer
Offering amount
$40M
Amount sold
$18M
Proceeds to insiders
$41.4K
First sale
Oct 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Crinetics nears shareholder vote on Vertex merger - TipRanks.comtipranks.com · Aug 2026First Trust Advisors LP Raises Stake in Crinetics Pharmaceuticals, Inc. $CRNXmarketbeat.com · Aug 2026Farallon reports 8.5% stake in Crinetics | CRNX SEC Filing - Form SCHEDULE 13G/Astocktitan.net · Aug 2026SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)newsfilecorp.com · Jul 2026Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNXbusinesswire.com · Jul 2026

Frequently asked questions

Who founded Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. was founded by Richard Scott Struthers, Stephen F. Betz.
Who are Crinetics Pharmaceuticals, Inc.'s investors?
Crinetics Pharmaceuticals, Inc.'s investors include Foresite Capital, Vivo Capital.
How much funding has Crinetics Pharmaceuticals, Inc. raised?
Crinetics Pharmaceuticals, Inc. has disclosed $428M raised across 3 rounds.
Where is Crinetics Pharmaceuticals, Inc. headquartered?
Crinetics Pharmaceuticals, Inc. is headquartered in San Diego, US.